Back to the NHL Newsfeed

Neurodegenerative Disorder Market Impressive CAGR +7% by 2028| Biogen, Pfizer, Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., UCB S.A., F. Hoffmann- La Roche Ltd., H. Lundbeck A/S, Merk KGaA, GlaxoSmithKline PLC, AbbVie Inc

Neurodegenerative disorders are illnesses that involve the death of certain parts of the brain. They are, by far, some of the toughest diseases to cure with debilitating outcomes. Parkinson’s and Huntington’s Disease are among the most severe and common movement disorders.

Alzheimer’s disease and Parkinson’s disease are the most common neurodegenerative diseases. In 2016, an estimated 5.4 million Americans were living with Alzheimer’s disease. An estimated 930,000 people in the United States could be living with Parkinson’s disease by 2020.

Dementia is a symptom of some neurodegenerative diseases, and may include memory loss and difficulties with thinking, problem-solving, or language.